Zacks Investment Research
14 May 2026, 14:55 UTC · 19w ago
Verdict
Headline takes no side. We score ACIU +0.60 across two claims — strongly bullish.
+0.60strongly bullish
More positive than 76% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Wall Street analysts have strong agreement in raising earnings estimates for AC Immune (ACIU).
More positive than 93% of claims this week
AC Immune (ACIU) stock formed a hammer chart pattern in its last trading session after losing 9.6% over the past four weeks.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 76% of ticker scores this week
The stock shows a bullish hammer chart pattern and has seen an upward trend in earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
−11.3%
Price is moving against the score
$2.52 vs $2.84 close before publication (May 13) · not market-adjusted
ACIU chart →
